Impact of Adverse Life Events on Neuroplasticity

不良生活事件对神经可塑性的影响

基本信息

  • 批准号:
    8335822
  • 负责人:
  • 金额:
    $ 31.43万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
  • 资助国家:
    美国
  • 起止时间:
  • 项目状态:
    未结题

项目摘要

Chronic stresses such as loss of a spouse or sleep deprivation, may cause memory impairments and increase susceptibility to AD. Experimental models of stress demonstrate impairments in spatial memory, contextual memory and object recognition in response to psychosocial or environmental stress. Yet, it remains to be determined if and how environmental stress modifies the cellular and molecular alterations that result in cognitive deficits in normal aging and in AD. We are employing mouse models to test the hypothesis that chronic psychosocial stress and sleep deprivation will accelerate the development of cognitive impairment in normal aging and in AD. Using the triple-transgenic AD mouse model (3xTgAD mice) we are determining the effects of chronic stress on amyloidogenes, tau pathology, synaptic dysfunction and learning and memory impairment. We are testing the hypothesis that aging and AD compromise adaptive cellular stress response pathways resulting in increased oxidative stress associated with reduced expression of neuroprotective proteins such as brain-derived neurotrophic factor (BDNF) and antioxidant enzymes. In related studies we have found that, in a model of type 2 diabetes, overeating results in hyperactivation of the neuroendocrine stress system, and that elevated levels of adrenal glucocorticoids impair hippocampal synaptic plasticity and neurogenesis, and that these stress-related alterations are associated with a deficit in cognitive function. Interestingly, regular exercise and dietary energy restriction can counteract the adverse effects of diabetes on hippocampal plasticity by a mechanism involving up-regulation of the expression of the neurotrophic factor BDNF. Chronic stress may be a risk factor for developing Alzheimer's disease (AD), but most studies of the effects of stress in models of AD utilize acute adverse stressors of questionable clinical relevance. We therefore undertook a study to determine how chronic psychosocial stress affects behavioral and pathological outcomes in an animal model of AD, and to elucidate underlying mechanisms. A triple-transgenic mouse model of AD (3xTgAD mice) and nontransgenic control mice were used to test for an affect of chronic mild social stress on blood glucose, plasma glucocorticoids, plasma insulin, anxiety, and hippocampal amyloid β-particle (Aβ), phosphorylated tau (ptau), and brain-derived neurotrophic factor (BDNF) levels. Despite the fact that both control and 3xTgAD mice experienced rises in corticosterone during episodes of mild social stress, at the end of the 6-week stress period 3xTgAD mice displayed increased anxiety, elevated levels of Aβ oligomers and intraneuronal Aβ, and decreased brain-derived neurotrophic factor levels, whereas control mice did not. Our findings suggest 3xTgAD mice are more vulnerable than control mice to chronic psychosocial stress, and that such chronic stress exacerbates Aβ accumulation and impairs neurotrophic signaling. Several mouse models of AD with abundant β-amyloid and/or aberrantly phosphorylated tau develop memory impairments. However, multiple non-mnemonic cognitive domains such as attention and executive control are also compromised early in AD individuals. Currently, it is unclear whether mutations in the β-amyloid precursor protein (APP) and tau are sufficient to cause similar, AD-like attention deficits in mouse models of the disease. To address this question, we tested 3xTgAD mice (which express APPswe, PS1M146V, and tauP301L mutations) and wild-type control mice on a newly developed touchscreen-based 5-choice serial reaction time test of attention and response control. The 3xTgAD mice attended less accurately to short, spatially unpredictable stimuli when the attentional demand of the task was high, and also showed a general tendency to make more perseverative responses than wild-type mice. The attentional impairment of 3xTgAD mice was comparable to that of AD patients in two aspects: first, although 3xTgAD mice initially responded as accurately as wild-type mice, they subsequently failed to sustain their attention over the duration of the task; second, the ability to sustain attention was enhanced by the cholinesterase inhibitor donepezil (Aricept). These findings demonstrate that familial AD mutations not only affect memory, but also cause significant impairments in attention, a cognitive domain supported by the prefrontal cortex and its afferents. Because attention deficits are likely to affect memory encoding and other cognitive abilities, our findings have important consequences for the assessment of disease mechanisms and therapeutics in animal models of AD.
慢性压力,如失去配偶或睡眠不足,可能会导致记忆障碍,并增加对AD的易感性。压力的实验模型表明,在空间记忆,上下文记忆和对象识别的心理社会或环境压力的损害。然而,环境压力是否以及如何改变导致正常衰老和AD中认知缺陷的细胞和分子改变仍有待确定。 我们正在使用小鼠模型来验证慢性心理社会压力和睡眠剥夺会加速正常衰老和AD中认知障碍发展的假设。 使用三转基因AD小鼠模型(3xTgAD小鼠),我们正在确定慢性应激对淀粉样蛋白基因、tau病理学、突触功能障碍以及学习和记忆障碍的影响。 我们正在测试的假设,老化和AD妥协适应性细胞应激反应途径,导致增加的氧化应激与神经保护蛋白,如脑源性神经营养因子(BDNF)和抗氧化酶的表达减少。 在相关研究中,我们发现,在2型糖尿病模型中,暴饮暴食导致神经内分泌应激系统过度激活,肾上腺糖皮质激素水平升高损害海马突触可塑性和神经发生,这些应激相关改变与认知功能缺陷相关。 有趣的是,定期运动和饮食能量限制可以抵消糖尿病对海马可塑性的不良影响,其机制涉及上调神经营养因子BDNF的表达。 慢性应激可能是发展阿尔茨海默病(AD)的危险因素,但大多数AD模型中应激作用的研究利用临床相关性可疑的急性不良应激源。因此,我们进行了一项研究,以确定慢性心理社会应激如何影响行为和病理结果的动物模型的AD,并阐明潜在的机制。使用AD的三重转基因小鼠模型(3xTgAD小鼠)和非转基因对照小鼠来测试慢性轻度社会应激对血糖、血浆糖皮质激素、血浆胰岛素、焦虑和海马淀粉样蛋白颗粒(A)、磷酸化tau(ptau)和脑源性神经营养因子(BDNF)水平的影响。尽管事实上,对照组和3xTgAD小鼠经历了轻微的社会应激发作期间皮质酮的上升,在6周的应激期结束时,3xTgAD小鼠表现出焦虑增加,A寡聚体和神经元内A水平升高,脑源性神经营养因子水平下降,而对照组小鼠没有。我们的研究结果表明,3xTgAD小鼠比对照组小鼠更容易受到慢性心理社会应激的影响,这种慢性应激加剧了A的积累并损害了神经营养信号。 具有丰富的β-淀粉样蛋白和/或异常磷酸化的tau的AD的几种小鼠模型发展记忆障碍。然而,多个非记忆的认知领域,如注意力和执行控制也受到损害的早期AD个人。目前,尚不清楚β-淀粉样前体蛋白(APP)和tau蛋白的突变是否足以在该疾病的小鼠模型中引起类似的AD样注意力缺陷。为了解决这个问题,我们测试了3xTgAD小鼠(表达APPswe,PS1 M146 V和tauP 301 L突变)和野生型对照小鼠的注意力和反应控制的基于触摸屏的5选择系列反应时间测试。当任务的注意力需求很高时,3xTgAD小鼠对短的、空间上不可预测的刺激的注意力不太准确,并且也表现出比野生型小鼠做出更持久反应的一般趋势。3xTgAD小鼠的注意力障碍在两个方面与AD患者的注意力障碍相当:首先,尽管3xTgAD小鼠最初的反应与野生型小鼠一样准确,但它们随后未能在任务期间维持注意力;其次,胆碱酯酶抑制剂多奈哌齐(Aricept)增强了维持注意力的能力。这些发现表明,家族性AD突变不仅影响记忆,而且还导致注意力的显著损害,注意力是由前额叶皮层及其传入支持的认知领域。由于注意力缺陷可能会影响记忆编码和其他认知能力,我们的研究结果对评估AD动物模型的疾病机制和治疗方法具有重要意义。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark Mattson其他文献

Mark Mattson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark Mattson', 18)}}的其他基金

Stem Cells And Neurogenesis
干细胞和神经发生
  • 批准号:
    7591990
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Stem Cells And Neurogenesis
干细胞和神经发生
  • 批准号:
    8335818
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Apoptosis In Neurodegenerative Disorders
神经退行性疾病中的细胞凋亡
  • 批准号:
    8736518
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Hormesis/Adaptive Stress Responses and Aging
毒物兴奋/适应性应激反应和衰老
  • 批准号:
    8736526
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Neuroprotective And Neurorestorative Signaling Mechanisms
神经保护和神经恢复信号机制
  • 批准号:
    8552362
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Cellular And Molecular Pathogenesis Of Alzheimer
阿尔茨海默病的细胞和分子发病机制
  • 批准号:
    8736517
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Synaptic Plasticity In Aging And Neurodegenerative Disorders
衰老和神经退行性疾病中的突触可塑性
  • 批准号:
    8736521
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Dietary Modification Of Brain Aging And Alzheimer's Disease
大脑衰老和阿尔茨海默病的饮食调整
  • 批准号:
    9770106
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Dietary Modification Of Brain Aging And Neurodegenerative Disorders
大脑衰老和神经退行性疾病的饮食调整
  • 批准号:
    8148215
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:
Hormesis/Adaptive Stress Responses and Aging
毒物兴奋/适应性应激反应和衰老
  • 批准号:
    8335823
  • 财政年份:
  • 资助金额:
    $ 31.43万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.43万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了